THE ANTIBODY-RESPONSE TO AN ORAL TY21A-BASED TYPHOID-CHOLERA HYBRID IS UNAFFECTED BY PRIOR ORAL VACCINATION WITH TY21A

被引：4

作者：

DEARLOVE, CE

FORREST, BD

VANDENBOSCH, L

LABROOY, JT

机构：

[1] ROYAL ADELAIDE HOSP, DEPT MICROBIOL & IMMUNOL, ADELAIDE, SA 5000, AUSTRALIA

[2] UNIV ADELAIDE, ADELAIDE, SA 5001, AUSTRALIA

[3] ENTEROVAX LTD, SALISBURY, AUSTRALIA

来源：

关键词：

D O I：

10.1093/infdis/165.1.182

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：182 / 183

页数：2

共 9 条

[1] PREVENTION OF SHIGELLOSIS BY A SALMONELLA-TYPHI-SHIGELLA SONNEI BIVALENT VACCINE
BLACK, RE
LEVINE, MM
CLEMENTS, ML
LOSONSKY, G
HERRINGTON, D
BERMAN, S
FORMAL, SB
[J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) : 1260 - 1265
[2] CURTISS R, 1989, CURR TOP MICROBIOL, V146, P35
[3] DIJOHN D, 1989, LANCET, V2, P1415
[4] DOUGAN G, 1989, ADV VET SCI COMP MED, V33, P271
[5] FORREST B D, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P449
[6] FORREST BD, 1988, LANCET, V1, P81
[7] A GALE-VIA (VI-ANTIGEN-NEGATIVE) MUTANT OF SALMONELLA-TYPHI TY2 RETAINS VIRULENCE IN HUMANS
HONE, DM
ATTRIDGE, SR
FORREST, B
MORONA, R
DANIELS, D
LABROOY, JT
BARTHOLOMEUSZ, RCA
SHEARMAN, DJC
HACKETT, J
[J]. INFECTION AND IMMUNITY, 1988, 56 (05) : 1326 - 1333
[8] SAFETY, IMMUNOGENICITY, AND EFFICACY AGAINST CHOLERA CHALLENGE IN HUMANS OF A TYPHOID-CHOLERA HYBRID VACCINE DERIVED FROM SALMONELLA-TYPHI TY21A
TACKET, CO
FORREST, B
MORONA, R
ATTRIDGE, SR
LABROOY, J
TALL, BD
REYMANN, M
ROWLEY, D
LEVINE, MM
[J]. INFECTION AND IMMUNITY, 1990, 58 (06) : 1620 - 1627
[9] ENTEROADHESION FIMBRIAE AND ENTERO-TOXIN OF ESCHERICHIA-COLI - GENETIC TRANSFER TO A STREPTOMYCIN-RESISTANT MUTANT OF THE GALE ORAL-ROUTE LIVE-VACCINE SALMONELLA-TYPHI TY21A
YAMAMOTO, T
TAMURA, Y
YOKOTA, T
[J]. INFECTION AND IMMUNITY, 1985, 50 (03) : 925 - 928